Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Bumetanide in Treatment of Autism Spectrum Disorder in Children

NCT04766177 is registered in ClinicalTrials.gov with Sherief Abd-Elsalam as lead sponsor.

NCT NCT04766177
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04766177 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Bumetanide in Treatment of Autism Spectrum Disorder in Children
Lead sponsor
Sherief Abd-Elsalam
Phase
Phase 3
Overall status
Recruiting
Start date
January 1, 2021
Completion date
December 1, 2030
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism